a Department of Psychology, University of Colorado Denver , Denver , CO , USA.
b Department of Psychiatry, University of Massachusetts Medical School , Worcester , MA , USA.
Am J Drug Alcohol Abuse. 2019;45(5):495-505. doi: 10.1080/00952990.2019.1620260. Epub 2019 Jun 27.
: Individuals with comorbid opioid addiction and pain (COAP) relapse 3-5 times more often than patients with opioid use disorder (OUD) but without pain. However, psychophysiological responses to pain among a COAP population are unknown. : We hypothesized that those on Medications for Opioid Use Disorder (MOUD) with chronic pain, relative to opioid-naïve chronic pain individuals, would show greater psycho-physiological pain reactivity and slower recovery when exposed to acute pain. : Four groups with chronic pain were recruited (N = 120; 60% Female): 1) MOUD-methadone; 2) MOUD-buprenorphine; 3) history of completed MOUD with prolonged opioid abstinence (PA; M = 121 weeks; SD = 23.3); and 4) opioid-naïve. We assessed heart rate (HR), galvanic skin conductance (GSC), peripheral temperature, and frontalis electromyography (EMG) during a cold pain task. : MOUD subjects had delayed HR reactivity to pain compared to those not on MOUD (PA & opioid-naïve; F(3,119) = 2.87, < .04). The PA group showed a normal HR reactivity pattern, but had higher HR compared to the opioid-naïve group. The GSC group x time analysis showed the PA group had greater baseline levels and pain reactivity than the other groups (F(3,119) = 3.84, < .02). The opioid-naïve group had lower reactivity on peripheral temperature compared to other groups (F(3,119) = 9.69, < .001). : Greater psychophysiological reactivity to pain was experienced by co-morbid OUD/chronic pain subjects who had been opioid abstinent for an extended period, possibly due to the lack of a buffering effect of opioid agonists. These subjects may develop coping skills to tolerate pain distress, thereby avoiding relapse in response to pain triggers. Understanding how pain creates more intense psychophysiological responses among COAP patients may lead to better treatments.
患有合并阿片类药物成瘾和疼痛(COAP)的个体比患有阿片类药物使用障碍(OUD)但无疼痛的个体更频繁地复发 3-5 次。然而,COAP 人群对疼痛的心理生理反应尚不清楚。
我们假设,与阿片类药物-naive 慢性疼痛个体相比,接受慢性疼痛治疗且正在服用阿片类药物治疗障碍(MOUD)的个体在暴露于急性疼痛时,会表现出更大的心理生理疼痛反应和更慢的恢复。
招募了四个慢性疼痛组(N=120;60%为女性):1)MOUD-美沙酮;2)MOUD-丁丙诺啡;3)完成 MOUD 且延长阿片类药物戒断(PA;M=121 周;SD=23.3);4)阿片类药物-naive。我们在冷痛任务中评估了心率(HR)、皮肤电导(GSC)、外周温度和额肌肌电图(EMG)。
与未接受 MOUD 治疗的个体相比,接受 MOUD 治疗的个体对疼痛的 HR 反应较慢(PA 和阿片类药物-naive;F(3,119)=2.87,<0.04)。PA 组表现出正常的 HR 反应模式,但与阿片类药物-naive 组相比 HR 较高。GSC 组 x 时间分析显示,PA 组的基线水平和疼痛反应均高于其他组(F(3,119)=3.84,<0.02)。与其他组相比,阿片类药物-naive 组的外周温度反应性较低(F(3,119)=9.69,<0.001)。
对疼痛的心理生理反应更强的是合并 OUD/慢性疼痛且已长期阿片类药物戒断的个体,这可能是由于阿片类激动剂的缓冲作用缺失所致。这些个体可能会发展出应对疼痛痛苦的技能,从而避免因疼痛触发而复发。了解疼痛如何在 COAP 患者中引起更强烈的心理生理反应可能会导致更好的治疗方法。